首页 > 市场调查报告书 > 医疗设备

e保健

市场调查报告书

商品编码

1316299

全球远程患者监护市场 - 2023-2030 年

Global Remote Patient Monitoring Market - 2023-2030

出版日期: 2023年07月27日 | 出版商:

DataM Intelligence | 英文 185 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概述

2022 年，全球远程患者监护市场规模达到 482 亿美元，预计到 2030 年将实现高达 3,389 亿美元的丰厚增长。在预测期内（2023-2030 年），全球远程患者监护市场的复合年增长率预计将达到 28.8%。

远程患者监护（RPM）是指在传统医院和医疗机构之外，利用先进的医疗物联网（IoMT）技术收集患者数据的医疗过程。它通过创造人们对自己的健康负责的环境，改善患者的行为。

远程病人监护设备的一些应用包括生物识别病人监护仪和虚拟护理平台。远程患者监护设备的最新趋势是使用基于云的患者监护平台，使医疗服务提供者能够实时访问患者数据，并为他们提供从远程位置更好地监护患者的能力。

推动全球远程患者监护设备发展的因素包括：慢性病发病率的上升、老年人口的增加、医疗服务可用性需求的增长、患者治疗效果的改善、医疗途径的增加以及效率的提高。

市场动态

技术进步推动远程患者监护市场增长

远程患者监护市场的技术进步推动了远程患者监护系统的发展。远程患者监护系统能够提供远程医疗服务，还有助于降低成本，提高医疗效果。

由于物联网（IoT）、云计算和人工智能等技术的进步，互联医疗的解决方案也在增加。例如，基于蓝牙的耳机可用于测量心率、体温和血压等生命体征。它可以帮助医生和保健从业人员从任何地点远程监控病人。

此外，随着智能手机应用程序的使用，远程病人监测变得更加高效和便捷。例如，"我的医疗 "应用程序可跟踪不同来源的健康信息，包括个人医疗记录和健身跟踪数据。因此，它有助于为患者提供定制计划，从而推动了远程患者监护市场的增长。

可穿戴设备在远程患者监护市场的使用增加推动了市场增长

患者监测设备、智能植入物和生物传感器中的可穿戴设备用于监测患者的慢性疾病，包括连续体温监测、血糖监测、脉搏血氧仪和血压监测。可穿戴设备拥有物联网等新一代先进技术。

例如，Apple Watch Series 4 具有跌倒检测和心电图功能，最近已获得美国食品及药物管理局批准，可用作评估心脏健康和检测心房颤动的非处方诊断工具。此外，Dexcom G6 和 FreeStyle Libre 等血糖监测设备可帮助糖尿病患者监测血糖水平，而无需刺破手指。

这些设备通常配有专用的智能手机应用程序，用户可以方便地查看数据。此外，这些设备还与物联网相连，使医生能够远程监控和管理病人的病情。可穿戴生物传感器可收集血压和心电图等重要体征。这些都是推动远程病人监护市场增长的主要因素。

与安装和培训过程相关的高成本阻碍了市场增长

安装远程病人监护系统的成本包括培训和安装费用，根据系统的复杂程度，费用从几百美元到几千美元不等。举例来说，一个仅能传递生命体征的基本系统的成本可能约为或低于 500 美元，而一个拥有多种系统的高级系统的成本可能超过 10,000 美元。

此外，RPM 系统的维护和更新费用也应纳入总支出中。随着时间的推移，定期维护、软件升级和技术支持服务可能会产生额外费用。此外，系统的可扩展性和定制选项也会影响其价格范围。

更先进的功能，如实时数据分析和预测性维护功能，可能会导致成本增加。但值得一提的是，投资于一个广泛的固体 RPM 系统可带来巨大的长期效益，如提高运营效率、减少停机时间和改善资产管理。

COVID-19 影响分析

COVID-19 大流行增加了对 RPM 系统的需求。医疗保健提供商已经找到了远程监控病人的方法，从而减少了到医院就诊的需要。因此，这导致了对 RPM 技术需求的增加和采用，扩大了远程医疗保健基础设施，促进了远程病人医疗保健。

RPM 系统能够早期发现和治愈 COVID-19 病例，帮助远程管理慢性疾病，减轻医疗系统的负担，提高患者的安全性，推动技术创新。因此，RPM 系统极大地改变了大流行期间的医疗保健服务，保证了护理的连续性，降低了暴露风险，对全球远程病人监护市场产生了积极影响。

设备
- 生命体征监护仪
- 血压计
- 脉搏血氧仪
- 心率监测仪（心电图）
- 体温监测仪
- 呼吸频率监护仪
- 脑监测仪（脑电图）
- 特殊监护仪
- 麻醉监护仪
- 血糖监测仪
- 心律监测仪
- 胎心监护仪
- 凝血酶原监测仪
- 多参数监护仪 (MPM)
服务与软件

第 8 章：按应用分类

心血管疾病
神经系统疾病
呼吸系统疾病
癌症
糖尿病
睡眠障碍
体重管理和体能监测
传染病

第 9 章：按最终用户分类

支付方
医疗机构
患者

第 10 章：按地区

北美洲
- 美国
- 加拿大
- 墨西哥
欧洲
- 德国
- 英国
- 法国
- 意大利
- 西班牙
- 欧洲其他地区
南美洲
- 巴西
- 阿根廷
- 南美洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 澳大利亚
- 亚太其他地区
中东和非洲

第 11 章：竞争格局

竞争格局
市场定位/份额分析
合併与收购分析

第十二章：公司简介

Medtronic Plc
- 公司概况
- 产品组合和说明
- 财务概况
- 近期发展
Koninklijke Philips N.V
GE Healthcare
Abbott Laboratories
BioTelemetry Inc.
Siemens Healthineers AG
Boston Scientific Corporation
Welch Allyn
OMRON Healthcare Co., Ltd.
Transtek

第 13 章：附录

简介目录

Product Code: MD74

Market Overview

The global remote patient monitoring market reached US$ 48.2 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 338.9 billion by 2030. The global remote patient monitoring market is expected to exhibit a CAGR of 28.8% during the forecast period (2023-2030).

Remote patient monitoring (RPM) is the healthcare process that uses Internet of medical things (IoMT) advancements for collecting patient data outside the traditional hospital and healthcare setup. It improves patient behaviour by creating the surrounding by which people are accountable and responsible for their health.

Some of the applications of remote patient monitoring devices are Biometric Patient Monitors and Virtual Care Platforms. The recent trends that are seen in remote patient monitoring devices are the use of cloud-based patient monitoring platforms allowing healthcare providers to access patient data in real-time and providing them with the ability to better monitor patients from remote locations.

The global remote patient monitoring is driven by the factors such as increasing prevalance of chronic disease, increase in the geriatric population and growing demands expansion in healthcare service avaliability, improved patient outcomes, increased access to care, increased efficiency.

Market Dynamics

Technological Advancements is Driving the Growth of Remote Patient Monitoring Market

The remote patient monitoring market has seen a rise in technology-driven advancements that are driving the growth of remote patient monitoring systems. Remote patient monitoring has the ability to provide access to healthcare from remote locations and also it helps reduce costs improving the results.

Solutions for connected health have increased due to the advancements in technologies such as the Internet of Things (IoT), Cloud Computing, and artificial intelligence. For instance, Bluetooth-based headsets are being used to measure vital signs such as heart rate, body temperature, and blood pressure. It helps doctors and healthcare practitioners to monitor patients remotely from any location.

Furthermore, with the use of smartphone apps, remote patient monitoring is becoming efficient and easier. For instance, My medical app tracks health information from different sources which includes personal medical records and fitness tracking data. Thus, it is useful to provide a customized plan for the patient and thus technological advancements are driving the growth of the remote patient monitoring market.

Increase in the Use of Wearables in Remote Patient Monitoring Market is Driving the Growth

Wearables in patient monitoring devices, smart implants and biosensors are used for monitoring chronic disease in the patient which includes continuous temperature monitoring, glucose monitoring, pulse oximetry and blood pressure monitoring. The wearables have next-generation advanced technologies such as the Internet of Things.

For instance, the Apple Watch Series 4, with its Fall Detection and ECG features, has recently been cleared by the FDA for use as an over-the-counter diagnostic tool for assessing cardiac health and detecting atrial fibrillation. Additionally, glucose monitoring devices such as the Dexcom G6 and FreeStyle Libre help diabetics to monitor their blood sugar levels without having to prick their fingers.

These devices often come with dedicated smartphone apps that allow users to conveniently view their data. Furthermore, these devices are connected to the Internet of Things, allowing physicians to remotely monitor and manage the conditions of their patients. Wearable biosensors collect important signs such as blood pressure, and electrocardiography. These are major factors which are driving the growth of the remote patient monitoring market.

High Cost Associated with the Installation and Training Process for RPM to Hamper the Market Growth

The cost of installing an remote patient monitoring system includes the cost of training and installation, which can range from a few hundred dollars to several thousand dollars depending on the system's complexity. A basic system that just communicates vital signs, for instance, may cost approximately or less than $500, whereas an advanced system with a wide range of systems may cost more than $10,000.

In addition, the cost of maintaining and updating the RPM system should be incorporated into the overall expenses. Over time, regular maintenance, software upgrades, and technical support services may incur additional costs. Furthermore, the scalability and customization options of the system can influence its price range.

More advanced features, such as real-time data analysis and predictive maintenance capabilities, may contribute to a higher cost. It is worth mentioning that however, that investing in an extensive solid RPM system can result in substantial long-term benefits such as greater operational efficiency, decreased downtime, and improved asset management.

COVID-19 Impact Analysis

The COVID-19 pandemic has increased the demand for RPM systems. Healthcare providers have found ways to remotely monitor patients,reducing the need for hospital visits. It has thus led to the increase in demand and adoption of RPM technology, expansion of telehealthcare infrastructure and facilitated remote patient healthcare.

RPM systems enabled early detection and cure of COVID-19 cases, helping managethe chronic conditions remotely reducing the burden on healthcare systems, enhancing the safety of the patient and driving innovation in technology. As a result, RPM systems have significantly transformed the delivery of healthcare during the pandemic by continuity of care and reduction of exposure risks and positively impacting the global remote patient monitoring market.

Segment Analysis

The global remote patient monitoring market is segmented based on product type, application, end-user and region.

Device Segment to Dominate the Market Owing to the Growing Adoption of Connected Devices

The device segment is expected to dominate the remote patient monitoring market with the market share of about 40.3% over the forecast period. The factors driving the device segment include increasing need for home healthcare, the increasing prevalence of chronic diseases and the growing adoption of connected devices.

For instance, in April, 26 2023, CardieX received FDA 510(K) clearance for a world-first vascular biometric monitor- the CONNEQT pulse, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Pulse is the only vital signs monitor targated at home, clinician, and clinical trial use measurements of both brachial blood pressure (the pressure at your arm) and central blood pressure (the pressure at your aorta/heart) in addition to multiple other vascular health biomarkers.

Geographical Analysis

North America's Region Dominating the Market Owing to the Increase in Adoption of Connected Healthcare Technology

Remote patient monitoring system is becoming increasingly popular in North America and the region is dominating the industry in a variety of ways with market share of about 41.1%. The North American region has dominated and is expected to dominate the remote patient monitoring system due to the increasing adoption of connected healthcare technology and the presence of top and leading market players in the region.

For instance, Medtronic recently announced the launch of its new Carelink Connected Remote Monitoring System which allows patients and healthcare providers to stay connected and collaborate in real-time. Similarly, Philips Healthcare has long been investing in services and technology related to remote monitoring systems.

The key drivers of market growth in the North American region include increasing demand for home healthcare services, increasing internet penetration, favourable government initiatives and the geriatric population. Moreover, the region has seen a rise in the no of hospitals introducing telehealth solutions, with the U.S. leading the way in the segment. For instance, Medicare and Medicaid Services (CMS) initiatives encourage doctors and other healthcare practitioners to embrace telehealth technologies.

Furthermore, the Department of Veterans Affairs in the United States has initiated a number of projects to boost the use of telehealth services, and the US government has provided incentives to institutions that use telehealth services. These measures have expanded telehealth usage in North America, adding to the overall growth of the market.

This has spurred the growth of the home healthcare services market, allowing the elderly to obtain quality healthcare services in the comfort of their own homes. With efforts such as the Department of Defence, the United States has been at the forefront of this expansion. Veterans Affairs and CMS are at the forefront of the telehealth sector.

Competitive Landscape

The major global players include: Medtronic Plc, Koninklijke Philips N.V, GE Healthcare, Abbott Laboratories, BioTelemetry Inc., Siemens Healthineers AG Boston Scientific Corporation, Welch Allyn, OMRON Healthcare Co., Ltd., Transtek among others.

Why Purchase the Report?

To visualize the global remote patient monitoring market segmentation based on product type, application, end-user, and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of remote patient monitoring market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global remote patient monitoring market report would provide approximately 61 tables, 61 figures and 185 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing prevalence of chronic diseases
  - 4.1.1.2. Increase in the geriatric population and growing need demands expansion in healthcare service availability
- 4.1.2. Restraints
  - 4.1.2.1. Lack of remote monitoring solution in low-income countries
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 7.1.2. Market Attractiveness Index, By Product Type
7.2. Devices*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  - 7.2.2.1. Vital Sign Monitors
  - 7.2.2.1.1. Blood Pressure Monitors
  - 7.2.2.1.2. Pulse Oximeters
  - 7.2.2.1.3. Heart Rate Monitor (ECG)
  - 7.2.2.1.4. Temperature Monitor
  - 7.2.2.1.5. Respiratory Rate Monitor
  - 7.2.2.1.6. Brain Monitor (EEG)
  - 7.2.2.2. Special Monitors
  - 7.2.2.2.1. Anesthesia Monitors
  - 7.2.2.2.2. Blood Glucose Monitors
  - 7.2.2.2.3. Cardiac Rhythm Monitors
  - 7.2.2.2.4. Fetal Heart Monitors
  - 7.2.2.2.5. Prothrombin Monitors
  - 7.2.2.2.6. Multi-Parameter Monitors (MPM)
7.3. Services & Software

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Cardiovascular Diseases*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Neurological Disorders
8.4. Respiratory Disorders
8.5. Cancer
8.6. Diabetes
8.7. Sleep Disorder
8.8. Weight management and Fitness Monitoring
8.9. Infectious Diseases

9. By End-User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Payers*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Providers
9.4. Patients

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. UK
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Spain
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Medtronic Plc*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Recent Developments
12.2. Koninklijke Philips N.V
12.3. GE Healthcare
12.4. Abbott Laboratories
12.5. BioTelemetry Inc.
12.6. Siemens Healthineers AG
12.7. Boston Scientific Corporation
12.8. Welch Allyn
12.9. OMRON Healthcare Co., Ltd.
12.10. Transtek

LIST NOT EXHAUSTIVE